Brentuximab vedotin, Cisplatin, Cytarabine, and Etoposide
About
Membership operator: AND
Therapies: 4
Therapies
Brentuximab vedotin (tx:ncit:C66944)
Cisplatin (tx:ncit:C376)
Cytarabine (tx:ncit:C408)
Etoposide (tx:ncit:C491)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| HSE (1) | CD30 + | Hodgkin Lymphoma | Brentuximab vedotin, Cisplatin, Cytarabine, Etoposide |